Neonatal Disease

Analysis of clinical features and risk factors of death in extremely preterm infants

  • Ye ZHANG ,
  • Min QI ,
  • Chunyan SHI ,
  • Shibing YANG ,
  • Zhou JIANG
Expand
  • Department of Neonatology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, Zhejiang, China

Received date: 2022-07-25

  Online published: 2023-10-08

Abstract

Objective To investigate the risk factors of death in extremely preterm infants (EPI). Methods The clinical data of EPI hospitalized in the neonatology department from January 1, 2018 to December 31, 2021 were retrospectively analyzed. According to the clinical outcome at the time of discharge, the patients were divided into the survival group and the death group, and the clinical characteristics between the two groups were compared to analyze the risk factors of EPI death. Results A total of 114 EPI patients (58 boys and 56 girls) were included. The median gestational age was 27.0 (26.0-27.6) weeks, the mean birth weight was (921±179) g, and 24 (21.1%) died. There were no significant differences in the proportions of advanced maternal age, cervical insufficiency, gestational diabetes mellitus, premature rupture of membranes, prenatal use of glucocorticoids and antibiotics between the two groups (P>0.05). Multivariate logistic regression analysis showed that birth weight ≤750g, severe neonatal respiratory distress syndrome, pulmonary hemorrhage within 1 week after birth, insulin use within 1 week after birth, and septic shock were independent risk factors for EPI death (P<0.05). Conclusions Body weight ≤750g, severe neonatal respiratory distress syndrome, septic shock, and pulmonary hemorrhage within 1 week after birth, or insulin use within 1 week after birth have a higher death risk in EPI.

Cite this article

Ye ZHANG , Min QI , Chunyan SHI , Shibing YANG , Zhou JIANG . Analysis of clinical features and risk factors of death in extremely preterm infants[J]. Journal of Clinical Pediatrics, 2023 , 41(10) : 665 -669 . DOI: 10.12372/jcp.2023.22e1118

References

[1] Stoll BJ, Hansen NI, Bell EF, et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012[J]. JAMA, 2015, 314(10): 1039-1051.
[2] Boel L, Banerjee S, Clark M, et al. Temporal trends of care practices, morbidity, and mortality of extremely preterm infants over 10-years in South Wales, UK[J]. Sci Rep, 2020, 10(1):18738.
[3] Bell EF, Hintz SR, Hansen NI, et al. Mortality, in-hospital morbidity, care practices, and 2-year outcomes for extremely preterm infants in the US, 2013-2018 [J]. JAMA, 2022, 327(3): 248-263.
[4] 邵肖梅, 叶鸿瑁, 丘小汕. 实用新生儿学[M]. 北京: 人民卫生出版社, 2010.
[5] Richardson DK, Corcoran JD, Escobar GJ, et al. SNAP-Ⅱ and SNAPPE-Ⅱ: simplified newborn illness severity and mortality risk scores[J]. J Pediatr, 2001, 138(1): 92-100.
[6] 李大金, 徐丛剑, 华克勤, 等. 实用妇产科学[M]. 4版. 北京: 人民卫生出版社, 2018.
[7] Weisz DE, Yoon E, Dunn M, et al. Duration of and trends in respiratory support among extremely preterm infants[J]. Arch Dis Child Fetal Neonatal Ed, 2021, 106(3): 286-291.
[8] 超未成熟儿与超低出生体重儿研究协作组. 广东省超未成熟儿与超低出生体重儿临床救治分析[J]. 中华儿科杂志, 2019, 57(12): 934-942.
[9] Kong X, Xu F, Wu R, et al. Neonatal mortality and morbidity among infants between 24 to 31 complete weeks: a multicenter survey in China from 2013 to 2014[J]. BMC Pediatr, 2016, 16(1): 174.
[10] 马俊苓, 刘鸽, 慕兴波, 等. 超早产儿早期存活情况与住院并发症分析[J]. 中华实用儿科临床杂志, 2019, 34(6): 430-434.
[11] Lee HC, Green C, Hintz SR, et al. Prediction of death for extremely premature infants in a population-based cohort[J]. Pediatrics, 2010, 126(3): e644-e650.
[12] 曹云. 极早/超早产儿救治及预后: 从提高存活率到关注生存质量[J]. 中华围产医学杂志, 2018, 21(6): 367-375.
[13] Ahmad KA, Bennett MM, Ahmad SF, et al. Morbidity and mortality with early pulmonary haemorrhage in preterm neonates[J]. Arch Dis Child Fetal Neonatal Ed, 2019, 104(1): F63-F68.
[14] 冯周善, 吴繁, 陈耀勇, 等. 2008—2017年超低出生体重早产儿临床救治分析[J]. 中华新生儿科杂志(中英文), 2019, 34(4): 269-274.
[15] Paulsen ME, Brown SJ, Satrom KM, et al. Long-term outcomes after early neonatal hyperglycemia in VLBW infants: a systematic review[J]. Neonatology, 2021, 118(5): 509-521.
[16] Zamir I, Tornevi A, Abrahamsson T, et al. Hyperglycemia in extremely preterm infants-insulin treatment, mortality and nutrient intakes[J]. J Pediatr, 2018, 200: 104-110.
[17] Beardsall K, Vanhaesebrouck S, Ogilvy-Stuart AL, et al. Early insulin therapy in very-low-birth-weight infants[J]. N Engl J Med, 2008, 359(18): 1873-1884.
[18] 胡月, 于慕刚, 李娟. 早产儿感染性休克的研究进展[J]. 国际儿科学杂志, 2020, 47(11): 796-799.
[19] Cnattingius S, Johansson S, Razaz N. Apgar score and risk of neonatal death among preterm infants[J]. N Engl J Med, 2020, 383(1): 49-57.
[20] Blundell P, Chakraborty M. Relationship between Apgar scores and morbidity and mortality outcomes in preterm infants: a single-centre cohort study[J]. Neonatology, 2020, 117(6): 742-749.
[21] McGoldrick E, Stewart F, Parker R, et al. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth[J]. Cochrane Database Syst Rev, 2020, 12(12): CD004454.
[22] Lee R, Williams EE, Dassios T, Greenough A. Influence of antenatal corticosteroids and sex on the mortality and morbidity of extremely prematurely born infants[J]. J Matern Fetal Neonatal Med, 2022, 35(25): 8062-8065.
[23] 超未成熟儿与超低出生体重儿研究协作组. 超未成熟儿与超低出生体重儿产前糖皮质激素使用情况及其对预后影响的多中心调查[J]. 中华围产医学杂志, 2020, 23(5): 302-310.
[24] Boghossian NS, Mcdonald SA, Bell EF, et al. Association of antenatal corticosteroids with mortality, morbidity, and neurodevelopmental outcomes in extremely preterm multiple gestation infants[J]. JAMA Pediatr, 2016, 170(6): 593-601.
[25] Dammann O, Shah B, Naples M, et al. Interinstitutional variation in prediction of death by SNAP-Ⅱ and SNAPPE-Ⅱ among extremely preterm infants[J]. Pediatrics, 2009, 124(5): e1001-e1006.
[26] Sotodate G, Oyama K, Matsumoto A, et al. Predictive ability of neonatal illness severity scores for early death in extremely premature infants[J]. J Matern Fetal Neonatal Med, 2022, 35(5): 846-851.
Outlines

/